Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
    • CHEST 2021
    • IDWeek 2021
    • IAS 2021
    • ADA 2021
    • ATS 2021
    • ACC 2021
    • ACP 2021
    • AAN 2021
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
    • CHEST 2021
    • IDWeek 2021
    • IAS 2021
    • ADA 2021
    • ATS 2021
    • ACC 2021
    • ACP 2021
    • AAN 2021
Departments

In reply: Postsurgical hypoparathyroidism is not primary hypoparathyroidism (March 2018)

Sohab S. Radwan, MD, Khair M. Hamo, MD and Ayman A. Zayed, MD, MSc, FACE, FACP
Cleveland Clinic Journal of Medicine October 2018, 85 (10) 736-737; DOI: https://doi.org/10.3949/ccjm.85c.10003
Sohab S. Radwan
The University of Jordan Amman, Jordan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Khair M. Hamo
The University of Jordan Amman, Jordan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ayman A. Zayed
The University of Jordan Amman, Jordan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

We thank Dr. Parmar and appreciate his important comments.

Regarding the difference between primary and secondary hypoparathyroidism, the definition varies among investigators. Some define primary hypoparathyroidism as a condition characterized by primary absence or deficiency of parathyroid hormone (PTH), which results in hypocalcemia and which can be congenital or acquired, including post-surgical hypoparathyroidism.1–4 In principle, this is similar to the classification of disorders affecting other endocrine glands as primary and secondary. For example, primary hypothyroidism refers to a state of low thyroid hormones resulting from impairment or loss of function of the thyroid gland itself, such as in Hashimoto thyroiditis, radioactive iodine therapy, or thyroidectomy, among others.5 We adopted this definition in our article. In contrast, secondary hypoparathyroidism is characterized by low PTH secretion in response to certain conditions that cause hypercalcemia. Non-PTH-mediated hypercalcemia is a more common term used to describe this state of secondary hypoparathyroidism.

Other investigators restrict the term “primary hypoparathyroidism” to nonacquired (congenital or hereditary) etiologies, while applying the term “secondary hypoparathyroidism” to acquired etiologies.6

Concerning the association between diabetes mellitus and hypomagnesemia, we agree that diabetes does not need to be uncontrolled to cause hypomagnesemia. However, the patient described in our article presented with severe hypomagnesemia (serum level 0.6 mg/dL), which is not commonly associated with diabetes. Most cases of hypomagnesemia in patients with type 2 diabetes mellitus are mild and asymptomatic, whereas severe manifestations including seizures, cardiac arrhythmias, and acute tetany are rarely encountered in clinical practice.7 Furthermore, numerous studies have shown a negative correlation between serum magnesium level and glycemic control.7–11 A recent study reported that plasma triglyceride and glucose levels are the main determinants of the plasma magnesium concentration in patients with type 2 diabetes.12

Our patient’s diabetes was uncontrolled, as evidenced by her hemoglobin A1c level of 9.7% and her random serum glucose level of 224 mg/dL. Therefore, it is more likely that “uncontrolled diabetes mellitus” (in addition to diuretic use) was the cause of her symptomatic severe hypomagnesemia rather than controlled diabetes mellitus.

  • Copyright © 2018 The Cleveland Clinic Foundation. All Rights Reserved.

REFERENCES

  1. ↵
    1. Mendes EM,
    2. Meireles-Brandão L,
    3. Meira C,
    4. Morais N,
    5. Ri-beiro C,
    6. Guerra D
    . Primary hypoparathyroidism presenting as basal ganglia calcification secondary to extreme hypocalcemia. Clin Pract 2018; 8(1):1007. doi:10.4081/cp.2018.1007
    OpenUrlCrossRef
    1. Vadiveloo T,
    2. Donnan PT,
    3. Leese GP
    . A population-based study of the epidemiology of chronic hypoparathyroidism. J Bone Miner Res 2018; 33(3):478–485. doi:10.1002/jbmr.3329
    OpenUrlCrossRef
    1. De Groot LJ,
    2. Chrousos G,
    3. Dungan K,
    4. et al.
    1. Hendy GN,
    2. Cole DEC,
    3. Bastepe M
    . Hypoparathyroidism and pseudohypoparathyroidism. In: De Groot LJ, , Chrousos G, , Dungan K, , et al., eds. Endotext [Internet], South Dartmouth (MA): MDText.com, Inc.; 2017. www.ncbi.nlm.nih.gov/books/NBK279165/. Accessed August 20, 2018.
  2. ↵
    1. Rosa RG,
    2. Barros AJ,
    3. de Lima AR,
    4. et al
    . Mood disorder as a manifestation of primary hypoparathyroidism: a case report. J Med Case Rep 2014; 8:326. doi:10.1186/1752-1947-8-326
    OpenUrlCrossRef
  3. ↵
    1. Almandoz JP,
    2. Gharib H
    . Hypothyroidism: etiology, diagnosis, and management. Med Clin North Am 2012; 96(2):203–221. doi:10.1016/j.mcna.2012.01.005
    OpenUrlCrossRefPubMed
  4. ↵
    1. Fouda UM,
    2. Fouda RM,
    3. Ammar HM,
    4. Salem M,
    5. Darouti ME
    . Impetigo herpetiformis during the puerperium triggered by secondary hypoparathyroidism: a case report. Cases J 2009; 2:9338. doi:10.1186/1757-1626-2-9338
    OpenUrlCrossRefPubMed
  5. ↵
    1. Tosiello L
    . Hypomagnesemia and diabetes mellitus. A review of clinical implications. Arch Intern Med 1996; 156(11):1143–1148. pmid:8639008
    OpenUrlCrossRefPubMed
    1. Pham PC,
    2. Pham PM,
    3. Pham PA,
    4. et al
    . Lower serum magnesium levels are associated with more rapid decline of renal function in patients with diabetes mellitus type 2. Clin Nephrol 2005; 63(6):429–436. pmid:15960144
    OpenUrlCrossRefPubMed
    1. Tong GM,
    2. Rude RK
    . Magnesium deficiency in critical illness. J Intensive Care Med 2005; 20(1):3–17. doi:10.1177/0885066604271539
    OpenUrlCrossRefPubMed
    1. Resnick LM,
    2. Altura BT,
    3. Gupta RK,
    4. Laragh JH,
    5. Alderman MH,
    6. Altura BM
    . Intracellular and extracellular magnesium depletion in type 2 (non-insulin-independent) diabetes mellitus. Diabetologia 1993; 36(8):767–770. pmid:8405745
    OpenUrlCrossRefPubMed
  6. ↵
    1. Pun KK,
    2. Ho PW
    . Subclinical hyponatremia, hyperkalemia and hypomagnesemia in patients with poorly controlled diabetes mellitus. Diabetes Res Clin Pract 1989; 7(3)163–167. pmid:2605984
    OpenUrlCrossRefPubMed
  7. ↵
    1. Kurstjens S,
    2. de Baaij JH,
    3. Bouras H,
    4. Bindels RJ,
    5. Tack CJ,
    6. Hoenderop JG
    . Determinants of hypomagnesemia in patients with type 2 diabetes mellitus. Eur J Endocrinol 2017; 176(1):11–19. doi:10.1530/EJE-16-0517
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 85 (10)
Cleveland Clinic Journal of Medicine
Vol. 85, Issue 10
1 Oct 2018
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
In reply: Postsurgical hypoparathyroidism is not primary hypoparathyroidism (March 2018)
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
In reply: Postsurgical hypoparathyroidism is not primary hypoparathyroidism (March 2018)
Sohab S. Radwan, Khair M. Hamo, Ayman A. Zayed
Cleveland Clinic Journal of Medicine Oct 2018, 85 (10) 736-737; DOI: 10.3949/ccjm.85c.10003

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
In reply: Postsurgical hypoparathyroidism is not primary hypoparathyroidism (March 2018)
Sohab S. Radwan, Khair M. Hamo, Ayman A. Zayed
Cleveland Clinic Journal of Medicine Oct 2018, 85 (10) 736-737; DOI: 10.3949/ccjm.85c.10003
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
    • REFERENCES
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Departments

  • Our Peer-Reviewers For 2022
  • An unexpected turn
  • Extraosseous calcification in kidney disease
Show more Departments

Letters to the editor

  • Antiobesity drug therapy
  • Physician resistance to obesity pharmacotherapy
  • In Reply: Antiobesity drug therapy
Show more Letters to the editor

Similar Articles

Subjects

  • Neurology
  • Endocrinology
  • Diabetes

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2023 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire